Érythropoïétine: Comparaison de trois trousses de dosage

Revue Francaise des Laboratoires

Volumn 2001, Issue 333, 2001, Pages 53-55

  De Bosredon, Karine ^a   Vuillemin, Luce ^a   Gobinet, Agnès ^a   Ducassou, Dominique ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Chemiluminescence; Chimiluminescence; ELISA; EPO; IRMA; Polycytemia vera; Vaquez

Indexed keywords

EID: 0346610123     PISSN: 03389898     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0338-9898(01)80165-7     Document Type: Article

References (10)

1. Canerskog J., Kutti J., Wadenvik H., Lundberg P.A., Lindstedt G. Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycytemia vera and essential thrombocythaemia. Eur. J. Haematol. 60:1998;278-282.
2. o 22. 1997;. Université de Bordeaux II.
3. Cotes P.M., Spivak J.L. Erslev A.J., Adamson J.W., Eschbach J.W., Winearls C.G. Erythropoietin in health and disease. Erythropoietin (molecular cellular and clinical biology). 1991;The Johns Hopkins University Press. chap. XI.
4. Dunn C.R.D., Lange R.D. Erythropoietin titers in normal human serum: an appraisal of as techniques. Exp. Hematol. 8:(3):1980;231-235.
5. Eschbach J.W., Egric J.C., Downing M.R., Browne J.K., Adamson J.W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a phase I and II clinical trial. N. Engl. J. Med. 316:1985;73-78.
6. Elkmann W. Erythropoietin: structure, control of production and function. Physiol. Rev. 72:1992;449-472.
7. Najean Y. Médecine nucléaire et hématologie, Médecine nucléaire - Imagerie fonctionnelle et métabolique. 23:(8):1999;517-523.
8. Prchal J.F., Axelrad A.A. Bone marrow responses in polycytemia vera. N. Engl. Med. 290:1974;1382.
9. Winearls C.G., Oliver D.O., Pippard M.J., Reid C., Downing M.R., Cottes P.M. Effects of human erythropoietin derived from recombinant DNA on the anemia of patients maintened by chronic hemodialysis. Lancet. 2:1986;1175-1177.
10. o 10 (suppl. 1) Nov. 15.